Document Type : Research articles


1 Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran . Center of Excellence in Nephrology, Tehran University of Medical Sciences, Tehran, Health Ministry, Iran.

2 Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran . Kerman University of Medical Sciences, Kerman, Iran .


Background: Chronic renal failure (CRF) and end-stage renal disease (ESRD) are among the underlying reasons for the hospitalization of expeditionary pilgrims to Mecca. This study aimed to evaluate the reasons and consequences of sending the patients with CRF and ESRD to Mecca to perform rites of pilgrimage.
Methods: This retrospective cross-sectional study assessed the profiles of all pilgrims in 2012 and 2013. The independent variables were awareness and unawareness of the patients with CRF and patients on dialysis; moreover, the dependent variables were reasons for referral and hospitalization in hospital, probable death rate, and indications of dialysis in an emergency.
Results: Out of all Pilgrims, 2416 (1.76% of the total pilgrims population) cases had CRF, out of whom 1.15%, 10.47%, and 88.36% of the patients were on dialysis, aware, and unaware of their disease, respectively. Furthermore, 93 (3.9%) patients with CRF were hospitalized during Hajj. Cardiovascular disease (41%) and respiratory diseases (20%) were the most common reasons for patients hospitalization.
Conclusion: It is suggested that the glomerular filtration rate of the pilgrims be calculated before sending them to Hajj; moreover, the patients with CRF should be screened accurately. Proper vaccination and cardio check-up are necessary before the Hajj expedition. Considering low-salt diet and adequate fluid intake in patients with CRF during Hajj can minimize patients' referral to hospitals.


  1. Serafi A. Pattern of cardiovascular diseases in pilgrims admitted in Al-Noor hospital Makkah during 1429H. Pak J Physiol. 2010; 6(1):14-7.
  2. Tabatabaei  A , Mortazavi M. Prevalence of underlying diseases in & Pilgrimage. Medical Congress in &  Pilgrimage  ,  Tehran, Iran ; 2011. P. 12.
  3. Ahmed QA, Arabi YM, Memish ZA. Health risks at the Hajj. Lancet . 2006;367(9515):1008-15. doi: 10.1016/S0140-6736(06)68429-8. [PubMed: 16564364].
  4. Al-Ghamdi SM, Akbar HO, Qari YA, Fathaldin OA, Al-Rashed RS. Pattern of admission to hospitals during Muslim pilgrimage (Hajj) . Saudi Med J. 2003;24(10):1073-6. [PMID: 14578971].
  5. Madani TA, Ghabrah TM, Albarrak AM, Alhazmi MA, Alazraqi TA, Althaqafi AO, et al. Causes of admission to intensive care units in the season of the Islamic year 1424 (2004). Ann Saudi Med. 2006;27(2):101-5. doi: 10.5144/0256-4947.2007.101. [PubMed: 17356316].
  6. Gautret P, Soula G, Delmont J, Parola P,  Brouqui P. Common health hazards in French pilgrims during the of 2007: a prospective cohort study. J Travel Med. 2009;16(6):377-81. doi: 10.1111/j.1708-8305.2009.00358.x. [PubMed: 19930376].
  7. Khan NA, Ishag AM, Ahmad MS, El-Sayed FM, Bachal ZA, Abbas TG. Pattern of medical diseases and determinants of prognosis of hospitalization during 2005 Muslim pilgrimage in a tertiary care hospital. A prospective cohort study. Saudi Med J. 2006;27(9):1373-80. [PubMed: 16951776].
  8. Madani TA, Ghabrah TM, Al-Hedaithy MA, Alhazmi MA, Alazraqi TA, Albarrak AM, et al. Causes of hospitalization of pilgrims during the Hajj period of the Islamic year 1423 (2003). Ann Saudi Med. 2006;26(5):346-51. doi: 10.5144/0256-4947.2006.346. [PubMed: 17019102].
  9. Hassannia T, Farzadfar F, Noori A, Moradi-Lakeh M, Delavari F, Jamshidi HR, et al. National and sub-national prevalence, trend, and burden of end stage renal diseases (ESRD) in Iran 1990-2013; the study protocol. Arch Iran Med. 2014;17(12):800-3. [PubMed: 25481317].
  10. Vachharajani TJ, Moist LM, Glickman MH, Vazquez MA, Polkinghorne KR, Lok CE, et al. Elderly patients with CKD--dilemmas in dialysis therapy and vascular access. Nat Rev Nephrol. 2014;10(2):116-22.  
  11. Hauser AB, Stinghen AE, Kato S, Bucharles S, Aita C, Yuzawa Y, et al. Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int. 2008;28(Suppl 3):S183-7. [PubMed: 18552253].
  12. de Jager DJ, Vervloet MG, Dekker FW. Noncardiovascular mortality in CKD: an epidemiological perspective. Nat Rev Nephrol. 2014;10(4):208-14. doi: 10.1038/nrneph.2014.8. [PubMed: 24492321].
  13. Noori N, Hosseinpanah F, Nasiri AA, Azizi F. Comparisonof overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr. 2009;19(3):228-37. doi: 10.1053/j.jrn.2008.11.005. [PubMed: 19261489].
  14. Tabatabaei  A, Eynolahi B. Prevalence of CKD in & pilgrimage. Medical Congress in & Pilgrimage  , Tehran,  Iran; 2011. P. 12 .
  15. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72(3):247-59. doi: 10.1038/ [PubMed: 17568785].
  16. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17-28. doi: 10.1038/ki.2010.483. [PubMed: 21150873].
  17. Ahn JH, Yu JH, Ko SH, Kwon HS, Kim DJ, Kim JH, et al. Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey. Diabetes Metab J. 2014;38(2):109-19. doi: 10.4093/dmj.2014.38.2.109. [PubMed: 24851205].
  18. Eckardt KU, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis--a position statement from KDOQI and KDIGO. Am J Kidney Dis. 2009;53(6):915-20 .doi: 10.1053/j.ajkd.2009.04.001. [PubMed: 19406541].
  19. Anand S, Khanam MA, Finkelstein FO. Global perspective of kidney disease. Nutrition in kidney disease 2014. Totowa, NJ: Humana Press; 2014. doi: 10.1007/978-1-62703-685-6_2.
  20. Dialysis Iranian Consortium. A comprehensive report on the status of patients with kidney failure in the world and Iran. Tehran: Dialysis Iranian Consortium; 2014.
  21. Statistical Center of Iran. Available at: URL:; 2014.
  22. Haghighi M, Heydari RA, Zamyadi M, Mahdavi MM, Nourouzi S, Rajolani H, et al. Dialysis in Iran. Iran J Kidney Dis. 2008;2(1):11-5.
  23. Mahdavi-Mazdeh M, Heidary Rouchi A, Norouzi S, Aghighi M, Rajolani H, Ahrabi S. Renal replacement therapy in Iran. Urol J. 2007;4(2):66-70. [PubMed: 17701924].
  24. Mahdavi-Mazdeh M, Zamyadi M, Nafar M. Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran. Nephrol Dial Transplant. 2008;23(1):288-93. doi: 10.1093/ndt/gfm580. [PubMed: 17965435].
  25. Aghighi M, Mahdavi-Mazdeh M, Zamyadi M, Heidary RA, Rajolani H, Nourozi S. Changing epidemiology of end-stage renal disease in last 10 years in Iran. Iran J Kidney Dis. 2009;3(4):192-6. [PubMed: 19841521].
  26. Larijani B, Javadi A, Shafaee A, Mahmoudi M, Baradar Jalilli R, Hemati P. Screening for microalbuminuria in the early detection of diabetic nephropathy: a cheap and simple method. Acta  Med Iran. 2002;40:65-8.
  27. Safarinejad MR. The epidemiology of adult chronic kidney disease in a population-based study in Iran: prevalence and associated risk factors. J Nephrol. 2009;22(1):99-108. [PubMed: 19229824].
  28. Mahdavi-Mazdeh M, Saeed Hashemi Nazri S, Hajghasemi E, Nozari B, Zinat Nadia H, Mahdavi A. Screening for decreased renal function in taxi drivers in Tehran, Iran. Ren Fail. 2010;32(1):62-8. doi: 10.3109/08860220903491190. [PubMed: 20113268].
  29. Hosseinpanah F, Kasraei F, Nassiri A, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009 ; 9:44 doi: 10.1186/1471-2458-9-44. [PubMed: 19183493].
  30. Noori N, Hosseinpanah F, Nasiri AA, Azizi F. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr. 2009;19(3):228-37. doi: 10.1053/j.jrn.2008.11.005. [PubMed: 19261489].
  31. Vachharajani TJ, Moist LM, Glickman MH, Vazquez MA, Polkinghorne KR, Lok CE, et al. Elderly patients with CKD--dilemmas in dialysis therapy and vascular access. Nat Rev Nephrol. 2014;10(2):116-22. doi: 10.1038/nrneph.2013.256. [PubMed: 24296629].
  32. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010;375(9722):1296-309. doi: 10.1016/S0140-6736(09)62004- 3. [PubMed: 20382326].
  33. Mathew T, Corso O. Review article: early detection of chronic kidney disease in Australia: which way to go? Nephrology (Carlton). 2009;14(4):367-73. doi: 10.1111/j.1440-1797.2009.01113.x. [PubMed: 19563377].
  34. Takazakura E, Sawabu N, Handa A, Takada A, Shinoda A, Takeuchi J. Intrarenal vascular changes with age and disease. Kidney Int. 1972;2(4):224-30.  doi: 10.1038/ki.1972.98. [PubMed: 4657923].
  35. Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A, et al. Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto. Nephrol Dial Transplant. 2000;15(Suppl 5):69-80. doi: 10.1093/ndt/15.suppl_5.69. [PubMed: 11073278].
  36. Fleischmann EH, Bower JD, Salahudeen AK. Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients? Clin Nephrol. 2001;56(3):221-30. [PubMed: 11597037].
  37. Herzog CA, Asinger RW, Berger AK, Charytan DM, Díez J, Hart RG, et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011;80(6):572-86. doi: 10.1038/ki.2011.223. [PubMed: 21750584].
  38. Ahmed A, Rich MW, Sanders PW, Perry GJ, Bakris GL, Zile MR, et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol. 2007;99(3):393-8. doi: 10.1016/j.amjcard.2006.08.042. [PubMed: 17261405].
  39. Ghanei H. Cardiovascular disease in the house of God before and after the pilgrims 1994. J Isfahan Univ  Med Sci. 1995;3 (4):290-3.
  40. Almalki WH. The prevalence of cardiovascular diseases and role of protective measures among hajj pilgrims 1432 (2011). Pak JPharmacol. 2012;29(2):29-34.
  41. Al-Asmary S, Al-Shehri AS, Abou-Zeid A, Abdel-Fattah M, Hifnawy T, El-Said T. Acute respiratory tract infections among medical mission personnel, Saudi Arabia. Int J Infect Dis. 2007;11(3):268-72. doi: 10.1016/j.ijid.2006.04.008. [PubMed: 16905350].
  42. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int. 2003;63(2):738-43. doi: 10.1046/j.1523-1755.2003.00787.x . [PubMed: 12631142].
  43. Danzinger-Isakov L, Kumar D; AST Infectious Diseases Community of Practice. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant. 2009;9(Suppl 4):S258-62. . doi: 10.1111/j.1600-6143.2009.02917.x. [PubMed: 20070687].
  44. Tabatabaei A, Mortazavi SM, Shamspour N, Shushtarizadeh N. Health knowledge, attitude and practice among Iranian pilgrims. Iran Red Crescent Med J. 2015;17(2):e12863. doi: 10.5812/ircmj.12863. [PubMed: 25838929].
  45. Sterns RH, Cox M, Feig PU, Singer I. Internal potassium balance and the control of the plasma potassium concentration. Medicine. 1981;60(5):339-54. doi: 10.1097/00005792-198109000-00002. [PubMed: 6268928].
  46. Mohamed AO, Sirwal IA, Bernieh B, Ahmed M. Patients on hemodialysis visiting madina munawarah: communication between nephrologists. Saudi J Kidney Dis Transpl. 2000;11(1):31-34. [PubMed: 18209295].